In 2024, China became the leader in cancer research output, overtaking the United States for the first time, with a substantial 19% increase in output as compared to a mere 5% increment in the U.S. The U.S. remains dominant in collaboration, leading in bilateral partnerships despite a decline in U.S.-China collaborations due to rising political tensions. Harvard University continues to excel individually, holding the top position in research output, significantly ahead of its closest competitor, the Chinese Academy of Sciences.
In 2024, China overtook the United States in cancer research output in the Nature Index for the first time, achieving notable growth in the field.
The United States remains the leader in cancer-research collaboration, being involved in the top 10 partnerships, although challenges persist due to political tensions.
Harvard University stands out with significant cancer-related research output, leading the pack against other institutions, including China's Academy of Sciences.
China's 19% increase in cancer research output signifies a shift in the global landscape of scientific research, particularly in oncology.
Collection
[
|
...
]